Is pancreatitis associated with meglumine antimoniate treatment for canine leishmaniosis? A multicentric prospective study
Meglumine antimoniate remains the first line leishmanicidal treatment option for canine leishmaniosis, but it appears to induce pancreatitis in a significant percentage of dogs. Monitoring serum cPLI levels and performing an abdominal ultrasound should be considered when pancreatitis-associated clinical signs are observed, or when there is a high suspicion of circulating immune complexes in dogs with advanced LeishVet clinical stage.
Authors
- María Cristina Lorente López (ORCID: https://orcid.org/0000-0003-2744-4077)
- Carolina Arenas (ORCID: https://orcid.org/0000-0002-5071-7689)
- Xavier Roura (ORCID: https://orcid.org/0000-0002-1098-2381)
- Clàudia Viñeta (ORCID: https://orcid.org/0000-0001-8668-5538)
- Maddalena Frau
- Jorge Castro (ORCID: https://orcid.org/0000-0002-1676-1723)
- A. Costas
Institutions
- Universitat Autònoma de Barcelona (ES)
- Menescalia Centro Veterinario (ES)
Publication Details
- Journal
- Parasites & Vectors
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1186/s13071-024-06617-7
- Citations
- 4
- Primary Topic
- Research on Leishmaniasis Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.17
Funders
- Elanco Animal Health